| (210) | Number of the EPO application | 16852695 |
| (220) | Filing date of the EPO application | 2016.09.30 |
| (80) | EPO patent specification publication (B) | EPB nr. 34/2021, 2021.08.25 |
| (110) | EPO patent number | 3356529 |
| (21) | Number of the application | e 2018 0779 |
| (71) | Name(s) of applicant(s), code of the country | Arrowhead Pharmaceuticals, Inc., US; |
| (72) | Name(s) of inventor(s), code of the country | MELQUIST Stacey, US;
KANNER Steven, US;
ROZEMA David B., US;
LEWIS David L., US;
ALMEIDA Lauren J., US;
WAKEFIELD Darren H, US;
TRUBETSKOY Vladimir S., US;
PEI Tao, US;
LI Zhen, US;
ALMEIDA Aaron, US; |
| (73) | Name(s) of owner(s), code of the country | Arrowhead Pharmaceuticals, Inc., US; |
| (54) | Title of the invention | COMPOSITIONS AND METHODS FOR INHIBITING GENE EXPRESSION OF LPA |
| (13) | Kind-of-document code | A1 |
| (51) | International Patent Classification | C12N 15/113 (2010.01.01) |
| (19) | Country | US |
| (41) | Date of publication of the application | 2018.09.30 |
| (30) | Priority | 201562235816 P, 2015.10.01, US; 201662346304 P, 2016.06.06, US; 201662383221 P, 2016.09.02, US |
| (86) | International application | PCT/US2016/054729, 2016.09.30 |
| (87) | International publication | WO 2017/059223, 2017.04.06 |